Armata Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	14.76	9.29	13.52	14.85	10.29	9.65
Cash & Short-Term Investments	14.76	9.29	13.52	14.85	10.29	9.65
Cash Growth	-13.91%	-31.30%	-8.95%	44.36%	6.62%	59.94%
Other Receivables	0.76	0.74	3.36	8.53	2.99	0.56
Total Trade Receivables	0.76	0.74	3.36	8.53	2.99	0.56
Other Current Assets	1.42	1.27	2.27	3.66	1.72	0.64
Total Current Assets	16.93	11.31	19.15	27.05	15	10.85
Net Property, Plant & Equipment	52.48	54.91	57.28	46.65	38.07	12.84
Other Intangible Assets	10.26	10.26	10.26	10.26	10.26	10.26
Goodwill	3.49	3.49	3.49	3.49	3.49	3.49
Other Long-Term Assets	6.36	6.46	8.19	8.39	2.96	2.09
Total Assets	89.52	86.44	98.36	95.83	69.77	39.52
Accounts Payable	1.99	2.06	5.69	6.03	2.27	1.93
Accrued Expenses	1.84	2.28	0.77	1.83	1.04	0.56
Short-Term Debt	131.08	38.95	-	-	-	0.72
Current Portion of Leases	4.53	4.43	9.48	17.01	1.51	1.55
Other Current Liabilities	0.51	0.53	0.52	-	-	1.94
Total Current Liabilities	139.95	48.25	16.46	24.87	4.81	6.71
Long-Term Debt	15.24	55.44	82.31	-	-	-
Long-Term Leases	26.84	27.69	28.58	31.8	36.48	10.88
Other Long-Term Liabilities	3.08	3.08	3.08	3.08	3.08	3.08
Total Long-Term Liabilities	45.15	86.21	113.97	34.88	39.56	13.95
Total Liabilities	185.1	134.46	130.43	59.75	44.37	20.66
Common Stock	0.36	0.36	0.36	0.36	0.27	0.19
Additional Paid-in Capital	281.39	279.35	276.39	275.49	227.98	198.37
Retained Earnings	-377.34	-327.73	-308.82	-239.77	-202.86	-179.7
Shareholders' Equity	-95.59	-48.02	-32.07	36.08	25.4	18.86
Total Liabilities & Equity	89.52	86.44	98.36	95.83	69.77	39.52
Total Debt	177.68	126.52	120.37	48.82	37.99	13.15
Net Cash (Debt)	-162.93	-117.22	-106.85	-33.96	-27.7	-3.5
Net Cash Per Share	-3.41	-1.99	-2.96	-0.99	-1.15	-0.21
Book Value	-95.59	-48.02	-32.07	36.08	25.4	18.86
Book Value Per Share	-2.00	-0.81	-0.89	1.05	1.05	1.15
Tangible Book Value	-109.33	-61.77	-45.81	22.33	11.65	5.11
Tangible Book Value Per Share	-2.29	-1.05	-1.27	0.65	0.48	0.31

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q